Nuclear Molecular Imaging of Cardiac Remodeling after Myocardial Infarction

Pharmaceuticals

Zohreh Varasteh¹  Wolfgang A. Weber¹  Christoph Rischpler² 

[1] Department of Nuclear Medicine, Klinikum Rechts der Isar der TUM, 81675 Munich, Germany;Department of Nuclear Medicine, University of Duisburg-Essen, German Cancer Consortium (DKTK)—University Hospital Essen, 45147 Essen, Germany;

关键词: myocardial infarction;    cardiac remodeling;    inflammation;    angiogenesis;    fibrosis;   

DOI  :  10.3390/ph15020183

来源: DOAJ

【 摘 要 】

The role of molecular imaging technologies in detecting, evaluating, and monitoring cardiovascular disease and their treatment is expanding rapidly. Gradually replacing the conventional anatomical or physiological approaches, molecular imaging strategies using biologically targeted markers provide unique insight into pathobiological processes at molecular and cellular levels and allow for cardiovascular disease evaluation and individualized therapy. This review paper will discuss currently available and developing molecular-based single-photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging strategies to evaluate post-infarction cardiac remodeling. These approaches include potential targeted methods of evaluating critical biological processes, such as inflammation, angiogenesis, and scar formation.

【 授权许可】

Unknown